LETTERS TO THE EDITOR

Letter to the editor: “Does a reduction in ADP-limited respiration indicate impaired mitochondrial function?”

to the editor: In a recent study, Dabkowski et al. (7) investigated the differential influence of streptozotocin-induced diabetes mellitus on interfibrillar and subsarcolemmal mitochondria in mice. They found decreased mitochondrial size, increased superoxide production, increased oxidative damage, and reduced complex activities. This was associated with impaired respiration rates (state 4) and impaired contractile function in diabetic mouse hearts. While the results appear consistent and the conclusion creditable, some technical modalities may affect the interpretation of the results, perspectives not considered in the article.

First, the authors measured mitochondrial respiratory activity in isolated mitochondria as basal, non-ADP-stimulated respiration, i.e., state 4 according to Chance and Williams (5). This respiration rate is not the maximal respiratory capacity, which is usually measured under ADP stimulation and termed “state 3 respiration” (4). It is the common notion that state 3 respiration reflects the maximal activity of the respiratory chain in isolated conditions when not limited by substrate, oxygen, or ADP (5). In contrast, state 4 respiration, as measured by Dabkowski et al. (7), is regarded as ADP-limited respiration (5) and is influenced by several factors, including the integrity of the inner mitochondrial membrane (8), the permeability of the outer membrane for protons (9), and the dissipation of the proton gradient through uncoupling proteins (2). The interpretation of isolated changes in state 4 respiration is still a matter of dispute. Increased state 4 respiration may indicate loose coupling (11) and may be regarded as beneficial (1, 6, 10) or detrimental (3). Irrespective of the interpretation, the nature of the changes in state 4 cannot really be assessed without knowing state 3 respiration. Since Dabkowski et al. (7) did not present the state 3 respiration rate, the true value of their finding of a decreased state 4 respiration cannot be determined. In theory, if a decrease in state 4 respiration, as described by the investigators, were associated with a normal state 3 respiration, the results would indicate a greater degree of coupling of the mitochondria, which would not be considered detrimental. This would significantly affect the interpretation of all the results.

Second, the authors measured mitochondrial function on complex I, II, and IV by assessing respiratory rates with complex-specific substrates and determined complex III activity with a biochemical spectroscopic assay. As respiratory rates test the function of the complete oxidative chain beyond the entrance of the electrons, they do not measure single complex activities. It was shown by Fannin et al. (8) that there may be significant differences between biochemically determined complex activities and mitochondrial respiration rates on one complex. These differences may be due to an altered inner membrane environment (8) or a different assembly of complexes into supercomplexes (12). Thus the supplementation of complex activity assessment by mixing the results of the two methods may lead to an erroneous interpretation.

REFERENCES

  • 1 Barros MH, Bandy B, Tahara EB, Kowaltowski AJ. Higher respiratory activity decreases mitochondrial reactive oxygen release and increases life span in Saccharomyces cerevisiae. J Biol Chem 279: 49883–49888, 2004.
    Crossref | PubMed | ISI | Google Scholar
  • 2 Boehm EA, Jones BE, Radda GK, Veech RL, Clarke K. Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart. Am J Physiol Heart Circ Physiol 280: H977–H983, 2001.
    Link | ISI | Google Scholar
  • 3 Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112: 2686–2695, 2005.
    Crossref | PubMed | ISI | Google Scholar
  • 4 Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, Abel ED. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56: 3457–2466, 2007.
    Google Scholar
  • 5 Chance B, Williams GR. A method for the localization of sites for oxidative phosphorylation. Nature 176: 250–254, 1955.
    Crossref | PubMed | ISI | Google Scholar
  • 6 Chen Q, Camara AK, Stowe DF, Hoppel CL, Lesnefsky EJ. Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am J Physiol Cell Physiol 292: C137–C147, 2007.
    Link | ISI | Google Scholar
  • 7 Dabkowski ER, Williamson CL, Bukowski VC, Chapman RS, Leonard SS, Peer CJ, Callery PS, Hollander JM. Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations. Am J Physiol Heart Circ Physiol 296: H359–H369, 2009.
    Link | ISI | Google Scholar
  • 8 Fannin SW, Lesnefsky EJ, Slabe TJ, Hassan MO, Hoppel CL. Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria. Arch Biochem Biophys 372: 399–407, 1999.
    Crossref | PubMed | ISI | Google Scholar
  • 9 Figueiredo PA, Powers SK, Ferreira RM, Appell HJ, Duarte JA. Aging impairs skeletal muscle mitochondrial bioenergetic function. J Gerontol A Biol Sci Med Sci 64: 21–33, 2009.
    PubMed | ISI | Google Scholar
  • 10 Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109–1122, 2006.
    Crossref | PubMed | ISI | Google Scholar
  • 11 Puchowicz MA, Varnes ME, Cohen BH, Friedman NR, Kerr DS, Hoppel CL. Oxidative phosphorylation analysis: assessing the integrated functional activity of human skeletal muscle mitochondria—case studies. Mitochondrion 4: 377–385, 2004.
    Crossref | PubMed | ISI | Google Scholar
  • 12 Rosca MG, Vazquez EJ, Kerner J, Parland W, Chandler MP, Stanley W, Sabbah HN, Hoppel CL. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc Res 80: 30–39, 2008.
    Crossref | PubMed | ISI | Google Scholar

AUTHOR NOTES

  • Address for reprint requests and other correspondence: T. Doenst, Dept. of Cardiac Surgery, Univ. of Leipzig Heart Center, Struempellstr. 39, Leipzig, 04178, Germany (e-mail: )